In psoriasis, like cancers, disease control that includes the well-being of a patient is an additional useful measure of ...

Genital psoriasis is common in psoriasis patients and shouldn't cause shame or interfere with your sex life, says ...

Jenifer Soung, MD, fo Southern California Dermatology, discussed how glucagon-like peptide-1 receptor agonists aid in treating patients with psoriatic disease. Captions are auto-generated.

Discover tips on navigating psoriasis treatments with resilience. Learn from a personal journey through six biologics, emphasizing hope and perseverance.

Eczema and psoriasis come with similar symptoms and therefore can be easy to confuse. Here's how to differentiate the two.

A recent review explored the benefits of biosimilars for patients with moderate to severe chronic plaque psoriasis.

First results from the BeNeBio study show that doses of IL-17 and IL-23 inhibitors can be reduced by up to 50% in people with ...

Icotrokinra demonstrated superiority to placebo and deucravacitinib in the treatment of adults and adolescents with moderate ...

Discover a study on psoriasis treatment failure, highlighting when to move from topical therapies to systemic care for ...

“Our findings suggest that GLP-1 receptor agonists may offer benefits beyond their effects on weight and glucose control, particularly for cardiovascular and psychiatric outcomes in people with ...

Adhering to a Mediterranean diet significantly improved disease severity among patients with psoriasis, independent of weight ...